Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month […]
Paul A Stone Sells 978 Shares of IDEAYA Biosciences, Inc (NASDAQ:IDYA) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
IGM Biosciences (NASDAQ:IGMS) Receives Sector Perform Rating from Royal Bank of Canada themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) shot up 4.7% during trading on Friday after JPMorgan Chase & Co. raised their price target on the stock from $28.00 to $32.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. IDEAYA Biosciences traded as high as $26.12 and last traded […]
Analysts Set IDEAYA Biosciences, Inc (NASDAQ:IDYA) Price Target at $29 40 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.